Hull Hans's Form 4 filing
Pliant Therapeutics, Inc. (PLRX) · filed Jan 22, 2025
- Accession no.
- 0001746473-25-000004
- Filed
- Jan 22, 2025
- Trade date
- Jan 17, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $178.5K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hull HansCIK 0001614876 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Common Stock | SSaleDisposed | −15,936 | $11.20 | −$178,483.2 | 211,558 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.